Published in Eur Respir J on March 01, 2002
Preliminary Study of Dornase Alpha to Treat Chest Infections Post Lung Transplant. | NCT01952470
Curcumin in Management of Chronic Obstructive Pulmonary Disease | NCT04687449
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax (2004) 2.78
Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes (2005) 2.42
Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2014) 2.28
Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax (2003) 2.11
Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res (2006) 2.03
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2007) 1.59
Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med (2011) 1.54
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality -- a systematic review. Respir Res (2005) 1.51
Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD. Int J Chron Obstruct Pulmon Dis (2008) 1.46
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res (2010) 1.31
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2007) 1.25
Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study. BMC Pulm Med (2011) 1.22
Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis (2009) 1.19
Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med (2012) 1.14
Using Telehealth technology to deliver pulmonary rehabilitation in chronic obstructive pulmonary disease patients. Can Respir J (2011) 1.12
COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis (2013) 1.09
Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol (2009) 1.06
Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD (2011) 1.06
Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency. Thorax (2003) 0.98
Minimal clinically significant difference in health status: the thorny path of health status measures? Eur Respir J (2002) 0.97
Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung (2004) 0.96
Temporal change in health-related quality of life: a longitudinal study in general practice 1999-2004. Br J Gen Pract (2009) 0.95
Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis. Clin Infect Dis (2013) 0.95
Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life. BMC Public Health (2009) 0.93
Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol. Int J Chron Obstruct Pulmon Dis (2013) 0.92
Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med (2009) 0.91
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD. Int J Chron Obstruct Pulmon Dis (2012) 0.89
St. George's Respiratory Questionnaire has longitudinal construct validity in lymphangioleiomyomatosis. Chest (2013) 0.89
Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med (2009) 0.88
High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One (2013) 0.88
Airway inflammation contributes to health status in COPD: a cross-sectional study. Respir Res (2006) 0.88
The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health Qual Life Outcomes (2014) 0.87
Comprehensive pulmonary rehabilitation in home-based online groups: a mixed method pilot study in COPD. BMC Res Notes (2015) 0.87
Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. BMC Pulm Med (2016) 0.86
Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.86
Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status. Int J Chron Obstruct Pulmon Dis (2011) 0.86
Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? BMC Pulm Med (2011) 0.86
PROLONG: a cluster controlled trial to examine identification of patients with COPD with poor prognosis and implementation of proactive palliative care. BMC Pulm Med (2014) 0.85
Descriptive analysis of the respiratory health status of persons exposed to Libby amphibole asbestos. BMJ Open (2012) 0.85
Observational studies of a one year self-management program and a two year pulmonary rehabilitation program in patients with COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.85
Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial. Respir Res (2012) 0.85
Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS). Health Qual Life Outcomes (2010) 0.85
Quality of life in lung transplantation. Semin Respir Crit Care Med (2013) 0.85
Tasmanian Aborigines step up to health: evaluation of a cardiopulmonary rehabilitation and secondary prevention program. BMC Health Serv Res (2014) 0.84
Danish version of the Oswestry disability index for patients with low back pain. Part 2: Sensitivity, specificity and clinically significant improvement in two low back pain populations. Eur Spine J (2006) 0.84
Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses. Int J Chron Obstruct Pulmon Dis (2015) 0.84
Behavioral and characterological self-blame in chronic obstructive pulmonary disease. J Psychosom Res (2011) 0.83
Reporting FDR analogous confidence intervals for the log fold change of differentially expressed genes. BMC Bioinformatics (2011) 0.83
Evaluation of the sustaining effects of Tai Chi Qigong in the sixth month in promoting psychosocial health in COPD patients: a single-blind, randomized controlled trial. ScientificWorldJournal (2013) 0.83
Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy. Int J Chron Obstruct Pulmon Dis (2013) 0.83
Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study. Am J Respir Crit Care Med (2016) 0.82
Impact of pulmonary arteriovenous malformations on respiratory-related quality of life in patients with hereditary haemorrhagic telangiectasia. PLoS One (2014) 0.82
Effects of an animated diagram and video-based online breathing program for dyspnea in patients with stable COPD. Patient Prefer Adherence (2013) 0.82
Determinants of health related quality of life in a sample of patients with chronic obstructive pulmonary disease in Nigeria using the St. George's respiratory questionnaire. Afr Health Sci (2013) 0.81
Taking Healthy Steps: rationale, design and baseline characteristics of a randomized trial of a pedometer-based Internet-mediated walking program in veterans with chronic obstructive pulmonary disease. BMC Pulm Med (2014) 0.81
Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study. Int J Chron Obstruct Pulmon Dis (2006) 0.81
Supported self-management for patients with COPD who have recently been discharged from hospital: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease. Health Qual Life Outcomes (2011) 0.81
Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis. Respir Res (2006) 0.80
Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results. BMC Pulm Med (2011) 0.80
Five-year follow-up of a one-year self-management program for patients with COPD. Int J Chron Obstruct Pulmon Dis (2012) 0.80
Pulmonary rehabilitation for COPD: are programs with minimal exercise equipment effective? J Thorac Dis (2014) 0.79
Pulmonary rehabilitation in emphysema. Proc Am Thorac Soc (2008) 0.79
Oximetry-supported self-management for chronic obstructive pulmonary disease: mixed method feasibility pilot project. BMC Health Serv Res (2015) 0.79
Are generic and disease-specific health related quality of life correlated? The case of chronic lung disease due to sulfur mustard. J Res Med Sci (2009) 0.78
Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. BMC Pulm Med (2015) 0.78
Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations. Int J Chron Obstruct Pulmon Dis (2016) 0.78
Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial. BMC Pulm Med (2017) 0.77
Value of supplemental interventions to enhance the effectiveness of physical exercise during respiratory rehabilitation in COPD patients. A systematic review. Respir Res (2004) 0.77
Nebulized formoterol: a review of clinical efficacy and safety in COPD. Int J Chron Obstruct Pulmon Dis (2010) 0.76
Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med (2016) 0.76
Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD. COPD (2013) 0.75
Distinct symptom experiences in subgroups of patients with COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Magnitude of exercise capacity and quality of life improvement following repeat pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Comparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trials. PLoS One (2015) 0.75
Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease. Core Evid (2005) 0.75
Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect. Int J Chron Obstruct Pulmon Dis (2014) 0.75
Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial. BMC Pulm Med (2014) 0.75
Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference. NPJ Prim Care Respir Med (2016) 0.75
ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis. JMIR Res Protoc (2015) 0.75
Interpreting patient-reported outcomes from clinical trials in COPD: a discussion. Int J Chron Obstruct Pulmon Dis (2016) 0.75
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Efficacy of a multidisciplinary pulmonary rehabilitation outpatient program on exacerbations in overweight and obese patients with asthma. Wien Klin Wochenschr (2017) 0.75
Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Methodological issues in evaluating measures of health as outcomes for COPD. Eur Respir J Suppl (2003) 0.82